Top NYC, NY Companies With Best Stability & Growth (10,000+)

Strong Revenue Growth: Reported 4.6× year-over-year growth preceding its 2025 Series B, alongside scale to $80B+ in AUM across 150+ fund vehicles. These signals indicate commercial momentum despite limited public financial disclosures.

Investor Backing & Capital Strength: Secured a $50M Series B in Nov 2025 led by Battery Ventures, bringing total funding to $76M with participation from existing investors. This capital-market validation aligns with reported rapid growth and ongoing hiring.

Market Expansion: Expanded from an initial focus on real estate into private equity and private credit, while more than doubling customers in 2025 to 21 firms and growing platform scale to $80B+ AUM. The July 2026 MCP integration also broadened how customers can connect the platform to AI agents.

Investor Backing & Capital Strength: Funding progression includes a reported Series A in 2023 and total capital in the mid‑teens of millions, indicating resources to scale operations and product. Named institutional investors and multiple rounds point to continued capacity to support growth initiatives.

Market Expansion: Positioning has broadened from forestry robotics into AI‑powered field operations for utilities, including vegetation management, asset inspection, construction, and disaster response. This shift suggests access to larger, higher‑value commercial segments.

Product Line Growth: Activity logs cite next‑generation backpack and vehicle hardware shipments, faster data processing, expanded species identification, and a desktop review application. These updates indicate ongoing investment in capabilities aligned to real‑world utility workflows.

Strong Revenue Growth: Revenue is scaling at strong double-digit rates, reaching $702M in FY2026 and continuing to rise in subsequent quarters, with full‑year FY2027 guidance lifted into the low‑$900M range. Multiple updates indicate momentum in both reported results and outlook.

Healthy Cash Flow: Operating cash flow turned positive in FY2026 and free cash flow was also positive, alongside progress in non‑GAAP profitability in later quarters. These milestones suggest improving financial efficiency as scale increases.

Diversified Customer Base: The company reports 12,500+ active customers and continued wins with large enterprises across technology, manufacturing, and healthcare. This breadth points to demand resilience across multiple industries.

Strong Revenue Growth: Net revenue increased 19% in FY2026 to about $2.5bn and rose a further 25% year over year to $714m in Q1 FY2027, indicating continued top-line momentum. Growth is broad-based alongside rising customers and cross-border volumes.

Profitability: Income before tax reached roughly $660m in FY2026, equating to a 26% margin while volumes and usage scaled. Profitability held even as the company reduced take rates to remain competitive.

Diversified Revenue Streams: Card spend grew 37% to ~$44bn and customer holdings rose ~40% to ~$39bn in FY2026, with card and other revenue also expanding, indicating monetization beyond transfer fees. Wise Platform partnerships with banks further extend revenue sources beyond direct consumer transfers.

Market Expansion: International footprint is described as rapidly scaling, with the oncology research network tripling year over year and later noted as nearly 70% ex‑U.S. growth across the UK, Germany, Japan, and new regions like Scotland. Point‑of‑care reach is also portrayed as expanding, with 1,600+ sites of care and increases from earlier baselines.

Product Line Growth: New offerings include the launch of Flatiron Telescope and multiple AI-enabled datasets, alongside expansions of major assets such as the NSCLC Panoramic dataset. Additional capabilities like LLM-based data extraction and new hematology datasets indicate broader, monetizable product breadth.

Strategic Partnerships: Collaborations are highlighted with organizations such as NCCN, Quest Diagnostics, Candid Health, TailorMed, and DeepScribe, as well as a multi‑year partnership alongside the Paradigm transaction. Engagements with 20+ global oncology drug developers and academic institutions reinforce a partnership‑driven operating model.

Profitability: Cash App gross profit has risen strongly over multiple periods, with momentum attributed to growth in Borrow, BNPL products, and the Cash App Card. Company communications indicate continued year-over-year expansion that has supported raised outlooks.

Diversified Revenue Streams: Multiple monetization pillars—consumer lending, card spend/commerce enablement, banking features, and payments—are contributing to growth, while Bitcoin-related revenue has relatively little impact on gross profit. Excluding Bitcoin, segment net revenue growth has been materially stronger, and per-active monetization has increased.

Strong Market Position & Advantage: The platform has built a very large transacting active base and ranks near the top of U.S. finance app downloads, supporting scale-driven advantages. Engagement indicators such as inflows per active and primary banking adoption have increased, signaling deepening usage.

Strong Revenue Growth: Revenue is rising at double-digit rates across recent periods, and management has increased full-year guidance, underscoring continued momentum. Growth is visible in both recent quarters and the prior year, indicating sustained top-line expansion.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with data-licensing/Insights activity increasing alongside clinical testing volumes. This mix reduces reliance on a single line of business and supports multiple growth vectors.

Strategic Partnerships: Collaborations with major biopharmaceutical companies and broader rollouts of platforms such as Next signal expanding commercial reach. Announced initiatives like a large whole‑genome dataset and work with firms including Merck reinforce external demand for the platform.

Strong Revenue Growth: Annualized revenue increased from $720M in March 2025 to $1.3B by March 2026, with ARR surpassing $1B in late 2025 and continuing upward. This trajectory points to sustained top-line momentum across the period cited.

Market Expansion: Geographic reach broadened with new regulated entries across multiple regions, alongside plans to deploy over $1B in the U.S. and substantial investment in Europe. Regional performance in the Americas and EMEA also advanced meaningfully, indicating traction beyond APAC.

Investor Backing & Capital Strength: Valuation rose from $6.2B (May 2025) to $11B (June 2026) through successive large funding rounds. Independent reporting corroborated the latest financing, signaling strong capital access and external confidence.

Investor Backing & Capital Strength: Capital raising is highlighted by a $60M Series D at a $1B valuation, bringing total funding to $138.5M, with third-party coverage corroborating the round and valuation. This capital is tied to expansion plans in AI, new markets, and hiring.

Market Expansion: The advisor network reportedly scaled from roughly 500 in 2022 to 15,000+ active advisors by 2026 across 180+ countries, including launches in Canada and Mexico. This points to broadening geographic reach and distribution capacity.

Product Line Growth: Expansion beyond a hotel-heavy business is evidenced by 70,000+ cruise bookings and $350M+ in cruise GMV by April 2026, with further moves into flights, groups, and enterprise. These additions indicate a widening portfolio that can increase wallet share.

Strong Revenue Growth: Company statements describe being on track for higher net revenue, and earlier filings documented substantial year-over-year expansion. Additional references point to rising contribution metrics over recent years.

Customer Loyalty & Retention: Company updates highlight record-high satisfaction and retention alongside a recent step-up in new-customer signups. These signals point to a stable, expanding customer base.

Product Line Growth: The business continues broadening its offering beyond core PEO into payroll, benefits, HR tools, and international employment, described under a “One Justworks” strategy. New capabilities and partnerships indicate ongoing investment in breadth.

Strong Revenue Growth: Available disclosures indicate revenue grew at a triple‑digit rate year over year in early 2026 and was later described as roughly $200M after multiple years of doubling. These signals point to rapid scaling beyond a purely funding‑led story.

Investor Backing & Capital Strength: Back‑to‑back late‑stage rounds in 2026, including a nine‑figure Series D followed quickly by a nine‑figure Series E with a stepped‑up valuation, suggest deep capital access and investor conviction. The rapid valuation increase provides additional financial flexibility for expansion.

Strategic Partnerships: Announcements in 2026 with organizations such as Atlantic Health and Priority Health indicate expanding distribution channels beyond direct employer sales. These relationships broaden market reach and embed the offering within health systems and plans.

Investor Backing & Capital Strength: Funding announcements describe a $27M Series A led by Emergence with participation from Lux and Susa, signaling resources to scale product and team. Additional references point to continued expansion activity, including new client migrations and an expanding footprint.

Innovation-Driven Growth: Materials consistently portray an AI-native fund administration platform built around a proprietary general ledger, automation, and integrated portfolio/LP features. Case studies and descriptions highlight rapid migrations and faster closes (e.g., Day‑0 financials), indicating product-led momentum.

Strong Hiring & Retention: Hiring pages list multiple open roles across engineering, product, go‑to‑market, fund accounting, and operations, suggesting active headcount growth. Third‑party listings also show a growing team band alongside ongoing recruitment.

Investor Backing & Capital Strength: Capital raised expanded meaningfully, including a $30M Series A in 2022 led by Optum Ventures with participation from Cigna Ventures, bringing total funding to about $40M. This capital base is presented as enabling expansion and signals strong support from prominent healthcare investors.

Product Line Growth: The company broadened from health‑plan administration to a healthcare‑data infrastructure platform with integrations, analytics, actuarial tools, and AI agents. Launches and deployments such as PBM connections and multiple vendor integrations indicate a widening offering and use cases.

Innovation-Driven Growth: Positioning centers on an integration platform for the payer ecosystem with elements like canonical data models, knowledge graphs, and agentic analytics, reflecting ongoing innovation. Evolving documentation and case activity reinforce a trajectory of product advancement rather than a static portfolio.

Profitability: Profitability is depicted as strong, with non-GAAP operating margins near 40% and improved GAAP net income. Feedback suggests this strength persists even amid slow top-line growth.

Healthy Cash Flow: Cash generation is highlighted as substantial, including FY2025 free cash flow above $1B and significant unlevered free cash flow in Q2 2026. Feedback suggests robust cash flow supports buybacks and financial flexibility.

Resilient & Sustainable Growth: Core operations are portrayed as stabilizing in 2026 with low single-digit revenue and ARR growth excluding FormSwift. Feedback suggests paying users have resumed modest sequential increases, indicating resilience.

Strong Revenue Growth: Financial disclosures show 2023 revenue up 17% to $1.012 billion, and annual run-rate revenue up 20% year over year to $1.1795 billion in 2024. This indicates sustained top-line momentum going into the take-private.

Product Line Growth: New offerings such as Squarespace Capital (2025) and Squarespace Balance (March 2026) expand the business from website creation into payments, financing, and business financial services. A 2025 partnership integrating capabilities into Perplexity’s Comet browser further broadens the product ecosystem.

Investor Backing & Capital Strength: The October 2024 take-private by Permira at approximately $7.2 billion explicitly aimed to support expansion and product development. This transaction underscores access to capital and sponsor support for continued scaling.

Strong Revenue Growth: Revenue is reported to have grown 4× in 2023, more than 300% in 2024, and then doubled again in 2025, indicating sustained acceleration. Company communications consistently point to multi‑year, triple‑digit expansion across successive periods.

Investor Backing & Capital Strength: Capital raised includes a $47M Series B in 2024 and a $72M Series C in 2025, bringing total funding to $162M. This level of financing from institutional and strategic investors signals ample resources to support scale.

Strategic Partnerships: Partnerships are described with 7–8 of the top 10 U.S. life insurers and additional organizations such as Prudential, Principal, and Aflac. This enterprise-led distribution has extended access to tens of millions of policyholders and employees.

Market Expansion: New enterprise wins and the move to serve firms from solo practices to large national enterprises point to a broadened addressable market. A New York City technology and sales hub and additional broker-dealer adoptions reinforce an expanding commercial footprint.

Product Line Growth: The acquisition of Parrot AI and its launch as a standalone advisor product, alongside offerings like a CRM+ for independent RIAs, indicate active portfolio expansion. Continued AI-native feature releases suggest investment in broader, deeper capabilities.

Future-Ready Strategy: Positioning as an AI-native wealth operating system and appointing a new CEO and CRO for the next phase of growth signal preparation for evolving market demands. Company statements about continued growth and organizational investment support a forward-looking posture.

Profitability: The company is described as privately held, profitable, and debt-free, indicating a solid financial base. This positioning supports continued investment without reliance on external financing.

Strong Revenue Growth: Revenue is reported above $1 billion with indications of year-over-year increases into 2024 and sustained scale into FY2025, while cloud segments are noted as expanding strongly. These signals point to ongoing top-line momentum.

Market Expansion: Operations span 28 countries with 38 offices serving customers in 80+ countries, alongside recent moves such as a dedicated public-sector subsidiary and added international presence. This footprint suggests continued geographic and channel growth.

Market Expansion: Alloy expanded into 40 countries in 2022 and later launched perpetual KYB and related offerings in the UK/Europe while adding an EMEA leadership team. These moves indicate ongoing geographic reach beyond the U.S.

Product Line Growth: The platform broadened from identity/onboarding into transaction monitoring, fraud prevention, perpetual KYC/KYB, risk-based authentication, and agentic AI. This widening scope increases platform relevance and potential revenue opportunities.

Strong Market Position & Advantage: Customer count rose from 700+ in June 2025 to 900+ by July 2026, showing substantial adoption across financial institutions and fintechs. Scale and continued uptake suggest a durable position in identity risk and fraud infrastructure.

Strong Revenue Growth: Disclosures indicate revenue grew 137% in 2024 and 160% in the first nine months of 2025, reaching $783.7M for that period. Gains in average daily client balances and trading volume further underscore broad-based top-line acceleration.

Profitability: Net income turned meaningfully positive, with $89.1M in 2024 and $157.2M in the first nine months of 2025. This profitability alongside rapid scaling supports financial stability.

Market Expansion: The company expanded beyond U.S. prime brokerage into UK and European equities (e.g., LSE clearing membership) and pursued APAC access via regulatory approvals and acquisitions. It also broadened offerings across futures, fixed income, options, digital assets, and investment banking.